维普期刊资源整合服务平台（V6.5）

188篇 您的检索式：作者名="HSU AL"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	The cyelooxygenase-2 inhibitor Celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2显示文摘	Hsu AL Ching TT Wang DS		0，，15：	1
2	Suplnvssion of allergic reactions hy dehulled adlay in association with the balance of Th1/Th2 cell re- sponses显示文摘	Hsu HY Lin BF Lin JY el al	2003	Journal of Agricuhural and Food Chemistry2003，51，13：	1
3	The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2 显示文摘	Hsu AL Ching TT Wang DS	2000	J Biol Chem2000，275，11：	1
4	Recent advances in non-surgical treatment for advanced hepatocellular carcinoma显示文摘	Hsu C Cheng JC Cheng AL	2004	J Formos Med Assoc2004，103，7：	1
5	Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high- risk or pre-maligant lesion 显示文摘	Cheng AL HSu CH Lin JK	2001	Anticancer Res2001，21，4：	1
6	PhaseⅠclinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions 显示文摘	Cheng AL Hsu CH Lin JK	2001	Anticancer Res2001，21，4：	1
7	Enhancing the out?put power of GaN-based LEOs grown on wet-etched patterned sapphire substrates显示文摘	LEE YJ HWANGJ M HSU T C er al	2006	IEEE Photonics Technology Letters2006，18，10：	1
8	Analysis of impairments influencing gait velocity and asymmetry of hemiplegic patients after mild to moderate stroke 显示文摘	Tang PF Jan MH	2003	Arch Phys Med Rehabil2003，84，8：	1
9	Clinical studies with curcumin 显示文摘	Hsu CH Cheng AL	2007	Adv Exp Med Biol2007，595，：	1
10	Hirayama flexion myelopathy:neutral-position MR imaging findings -importance of loss of attach-ment显示文摘	Chen CJ Hsu HL Tseng YC ef al	2004	Radiology2004，231，1：	1
11	Magnetic resonance myocardial fiber-orientation mapping with direct histological correlation显示文摘	Hsu EW Muzikant AL Matulevicius SA	1998	Am J Physiol1998，274，：	1
12	Evidence for directprotein kinase-C mediated modulation of N-methyl-D-aspartatereceptor current显示文摘	Liao G Y Wagner D A Hsu M H e( al	2001	Mol Pharmacol2001，59，5：	1
13	Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions显示文摘	Cheng AL Hsu CH Lin JK	2001	Anticancer Res2001，21，4：	1
14	The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks显示文摘	Johnson AJ Hsu AL Lin HP	2002	Biochem J2002，366，3：	1
15	A pros- pective, randomized trial of endoscopic hemoclip placement and distilled water injection for treatment of high-risk bleeding ulcers显示文摘	Chou YC Hsu PI Lai KH e t al	2003	Gastrointest-Endosc2003，57，3：	1
16	Regulation of aging and age-related disease by DAF-16 and heat-shock factor显示文摘	Hsu AL Murphy CT Kenyon C	2003	Science2003，300，5622：	1
17	Analysis of impairments influencing gait velocity and asymmetry of hemiplegic patients after mild to moderate stroke显示文摘	Hsu AL Tang PF Jan MH	2003	Arch Phys Med Rehabil2003，84，：	1
18	The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2 显示文摘	Hsu AL Ching TT Wang DS	2000	J Biol Chem2000，275，11：	1
19	The cyclooxygenase-2 inhibitor Celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2显示文摘	Hsu AL Ching TT Wang DS	2000	J Biol Chem2000，275，11：	1
20	Phase I chinical trial of curcumin,a chemopreventive agent, in prients with high - risk or pre - malignant lesions显示文摘	Hsu CH Lin JK	2001	Anticancer Res2001，21，：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示